ADAKVEO (Crizanlizumab)
ADAKVEO is indicated to reduce the frequency of vasoocclusive crises (VOCs) in adults and pediatric patients aged 16 years and older with sickle cell disease. ADAKVEO is a selectin…
Novartis Pharmaceuticals Corporation Products: Prescription Medications Section
Afinitor (Everolimus)
AFINITOR is a kinase inhibitor indicated for the treatment of: Postmenopausal women with advanced hormone receptor-positive. HER2-negative breast cancer in combination with exemestane…
Amturnide (Aliskiren Hemifumarate and Amlodipine Besylate and Hydrochlorothiazide)
Amturnide is indicated for the treatment of hypertension, to lower blood pressure. Lowering blood pressure reduces the risk of fatal and nonfatal cardiovascular events, primarily strokes and myocardial infarctions. These benefits have been seen in…
Arcapta Neohaler (Indacaterol Maleate)
ARCAPTA NEOHALER is a long-acting beta 2 -adrenergic agonist indicated for: The long term, once-daily maintenance bronchodilator treatment of airflow obstruction in patients with chronic obstructive pulmonary disease (COPD), including chronic…
ARGATROBAN
Argatroban is a direct thrombin inhibitor indicated: For prophylaxis or treatment of thrombosis in adult patients with heparin-induced thrombocytopenia (HIT) (1.1) As an…